Dr. Xin Zhou is an Oxford-Bristol Myers Squibb Fellow at the Department of Computer Science, University of Oxford. Her research integrates computational modeling, clinical data, and experimental findings to investigate cardiac disease mechanisms and develop human-based simulations for drug evaluation. BSc and MSc in Life Sciences, Beijing Normal University DPhil in Computational Biology, University of Oxford Her work focuses on multi-scale cardiac modeling , particularly in ischemic heart disease and heart failure, exploring ionic currents, tissue conduction, and organ-level dynamics. She develops electromechanical simulations to study cardiac alternans and arrhythmic risks, translating these into clinical applications for patient stratification and pharmaceutical testing. Recent publications emphasize in silico clinical trials , sex-specific cardiometabolic analysis, and Purkinje network modeling. Collaborative efforts with clinicians and pharmaceutical partners highlight her translational approach to regulatory science. Model of the Year 2024, BioModels EPSRC Impact Acceleration Account Microsoft Research Project Award Recognition Award, University of Oxford She supervises PhD and MSc students in computational cardiology, while serving on the editorial board of Frontiers in Physiology . Her current projects involve digital twinning and predictive cardiac safety models to reduce animal testing reliance.
Molly Maleckar is a Research Professor at the Computational Physiology Department of Simula Research Laboratory , Oslo, Norway. Her work bridges computational modeling, cardiac electrophysiology, and biomedical applications, with a focus on arrhythmia mechanisms, fibrosis modeling, and machine learning integration in cardiac risk prediction. Research Interests include: Computational Cardiology Ion Channel Dynamics Machine Learning in Medicine Excitable Tissue Modeling Cardiac Fibrosis Analysis Biomedical Simulation Scientific Contributions span 15+ publications (2018-2024) addressing atrial fibrillation, calcium handling, and AI-driven ECG analysis. Key collaborative projects involve patient-specific ventricular modeling and educational initiatives like the Simula Summer School in Computational Physiology .
Markus Babst is a Professor of Biological Sciences at the University of Utah, where he leads research at the Center of Cell and Genome Science. His work focuses on protein trafficking mechanisms in eukaryotic cells using Saccharomyces cerevisiae as a primary model system. His educational background includes: Diploma from Federal Institute of Technology, Switzerland Ph.D. from Federal Institute of Technology, Switzerland Dr. Babst's research centers on post-translational regulation of plasma membrane proteins through endocytosis and endosomal sorting. Key investigations include ESCRT-mediated protein sorting into multivesicular bodies for lysosomal degradation and eisosome-regulated storage of nutrient transporters. His work demonstrates how calcium signaling and proton gradients control eisosome disassembly and transporter endocytosis, revealing fundamental mechanisms of cellular stress adaptation. This research bridges membrane biophysics, metabolic regulation, and organelle dynamics. Analysis of his 15 most recent publications shows persistent thematic focus on membrane tension regulation, ESCRT complex dynamics, and nutrient transporter control. His work increasingly integrates mitochondrial metabolism with plasma membrane organization while maintaining yeast genetics as the core methodology. Recurring subfields include membrane contact sites, lipid domain organization, and stress-induced protein trafficking changes. Dr. Babst's scientific contributions are evidenced by his extensive publication record in high-impact journals, though specific awards are not documented in available sources. While student mentorship details are unavailable in the provided materials, his laboratory employs biochemical, genetic, and cell biological approaches to investigate membrane protein regulation. Grant funding specifics are not mentioned in the source text. His laboratory operates within the University of Utah's biological research ecosystem, utilizing S. cerevisiae to dissect conserved eukaryotic mechanisms. Current work emphasizes plasma membrane tension dynamics, ER-plasma membrane contact sites, and metabolic regulation of membrane protein trafficking, with implications for understanding cellular adaptation in changing environments.
Professor Richard Wade-Martins is a leading academic in University of Oxford 's Department of Physiology, Anatomy and Genetics . He directs the Molecular Neurodegeneration Research Laboratory and the Oxford Parkinson’s Disease Centre (OPDC). With degrees from Cambridge (MA) and Oxford (DPhil), he has held prestigious fellowships including Wellcome Trust Research Career Development Fellowship and NIH reviewer roles. His research targets molecular mechanisms in Parkinson’s and Alzheimer’s diseases through iPSC models , transgenic mice , and lysosomal function studies . He pioneered work on SNCA , MAPT , and LRRK2 gene pathways. Current projects focus on gene therapy and mitochondrial dysfunction in neurodegeneration. Key publications (2019–2025) reveal trends in single-cell transcriptomics , calcium channel inhibition , and TFEB/TFE3 lysosome modulation . His awards include Wellcome Trust Fellowships and advisory roles for Parkinson's UK , Alzheimer's Research UK , and EU consortia like StemBANCC and EFACTS . He leads the UK Dementia Platform iPSC Initiative and serves on international boards in Luxembourg and Canada.
Prof. Stephan J. Sigrist is a Full Professor of Genetics at the Institute of Biology, Free University of Berlin. His lab focuses on synaptic active zone architecture, neuroplasticity, and aging-related neurodegeneration. He leads the Collaborative Research Center 958 on Membrane Scaffolding and co-directs NeuroCure, a DFG Cluster of Excellence at Charité. Education: PhD in Molecular Genetics (1997) and Habilitation (2005) from the University of Göttingen. Positions: Einstein Professor (2014–present), Spokesperson CRC 958 (2012–present), and Co-Director NeuroCure (2009–present). Research explores presynaptic mechanisms using Drosophila and mouse models, combined with STED microscopy. Key contributions include discoveries of Bruchpilot's role in active zones and spermidine's protective effects against age-related synapse decline. Grants: Over €6 million in funding, including DFG CRCs, Einstein Foundation, and ERC Advanced Grant (2025). Awards: Einstein Professorship, Best Habilitation Award, EMBO/HFSP Fellowships. Collaborations span structural biology (e.g., Stefan Hell), neurophysiology (David DiGregorio), and aging research (Frank Madeo).
Vignesh Ram Somnath is a Professor in the Biosciences of Sports at the University of Hildesheim since 2018. Previously, he served as an Acting Professor (2016-2018) and Research Associate (2010-2016) at the Institute of Sports Science, German Sports School Cologne. His work bridges molecular biology with sports science, focusing on skeletal muscle adaptation. Current: University Professor W2, University of Hildesheim 2016-2018: Acting Professor, University of Hildesheim 2010-2016: Research Associate, German Sports School Cologne 2005-2007: Research Assistant, German Sports School Cologne Research Interests: Regulation of molecular signaling pathways in skeletal muscle Mechanoprotective mechanisms during exercise Protein degradation dynamics Optimization of training and nutrition in competitive sports Integration of molecular biology with traditional sports science Key Publications (2020-2017) demonstrate expertise in: Metabolomics of muscle hypertrophy AMPK signaling in training Mitochondrial adaptations Extracellular vesicle analysis Calcium signaling pathways
Nicholas M. Kanaan is a Professor of Translational Neuroscience and holds the Maibach Smiley Professorship of Alzheimer's Research at Michigan State University's College of Human Medicine. He serves as Director of Advanced Microscopy and is faculty in both the MSU Neuroscience Program and the MSU BioMolecular Science Gateway. His research is centered at the Grand Rapids Research Center where he leads the Kanaan Laboratory. Dr. Kanaan received his B.S. in Neuroscience, Psychology, and Sociology from Central Michigan University in 2001, followed by a Ph.D. in Neurological Sciences from Rush University Medical Center in 2007. He completed postdoctoral training at Northwestern University from 2007-2010 under Dr. Lester Binder. His research focuses on neurodegenerative diseases, particularly Alzheimer's disease (AD) and Parkinson's disease (PD), with emphasis on tau protein pathology. The Kanaan Lab investigates mechanisms underlying degenerative diseases using a combination of in vitro and in vivo model systems. A major focus is understanding how disease-related alterations in tau cause neuronal dysfunction through disruption of axonal transport. His lab has identified a phosphatase-activating domain (PAD) in tau that inhibits anterograde fast axonal transport. Analysis of Dr. Kanaan's publication record reveals a consistent focus on tau protein biology, with recent work emphasizing iPSC models, CRISPR screening, tau proteostasis, and therapeutic interventions targeting tau phosphorylation and oligomerization. His research spans basic molecular mechanisms to translational applications, with increasing use of primate models and advanced screening technologies in recent years. Scientific Awards and Recognition: Maibach Smiley Alzheimer's Research Professor Maibach Smiley Professor of Alzheimer's Research Dr. Kanaan mentors numerous students and postdoctoral fellows in his laboratory, with research supported by multiple grants focused on understanding and treating neurodegenerative diseases. His lab employs a wide range of technical expertise including recombinant protein purification, cell culture, monoclonal antibody production, various microscopy techniques, and behavioral testing in rodent models. Outside the lab, Dr. Kanaan enjoys photography, woodworking, and fishing.
Ueli Grossniklaus is an Ordinary Professor at the University of Zurich within the Faculty of Mathematical and Natural Sciences , affiliated with the Department of Plant and Microbiology . His work focuses on plant developmental biology, particularly epigenetic and genetic mechanisms governing reproduction and adaptation. Key Courses: Epigenetics, Plant Biology Workshop, Group Seminars on Current Research Laboratory Techniques: Advanced methods in plant cell mechanics, transcriptomics, and genome editing Research Interests span plant epigenetics, reproductive biology, and the interplay between environmental stress and genetic regulation. He investigates: Mechanistic control of gametogenesis and fertilization Epigenetic contributions to plant adaptation Evolutionary implications of asexual reproduction Biophysical forces in plant cell growth Publication Trends (2025–2018) reveal expertise in: Arabidopsis and fern model systems Epigenetic regulation (DNA methylation, histone dynamics) Apomixis and hybrid seed failure mechanisms Biomechanics of pollen tubes and carnivorous plants Genome editing tools (CRISPR) and long-read sequencing Scientific Collaborations include interdisciplinary projects on: Microfluidic devices for plant cell analysis Gene drive ecology and ethics 3D imaging of plant reproductive structures Advising and Grants focus on mentoring through research internships in developmental biology, genetics, and systems biology. His lab engages in: Epigenetic response to environmental stress Cell wall mechanics in reproduction Computational modeling of plant growth Laboratory Teams integrate plant biologists, bioengineers, and computational scientists to study: Mechanistic gene regulation Evolutionary developmental biology Microrobotics for cellular force measurement
Prof. Wouter Roos is a Professor at the University of Groningen's Faculty of Science and Engineering, affiliated with the Molecular Biophysics department at the Zernike Institute for Advanced Materials. His research focuses on viral dynamics, membrane assemblies, and protein mechanics, utilizing advanced techniques like High Speed Atomic Force Microscopy (HS-AFM) and optical tweezers. Education: Studied Physics at the Universiteit van Amsterdam, earned a PhD from the Universität Heidelberg under Joachim Spatz. Conducted postdoctoral research at Max-Planck-Institut, Institut Curie, and Vrije Universiteit before joining Groningen in 2015. Research Interests: Physical Virology (viral material properties and dynamics), membrane biophysics (synthetic cells and lipid interactions), and molecular motor systems. His work bridges physics, chemistry, and biology to understand nanoscale biological processes. Recent Article Trends: Studies on hybrid membranes for synthetic cells, leukemic cell mechanics, and antibiotic-membrane interactions highlight his interdisciplinary approach. Key techniques include HS-AFM and single-particle tracking. Awards: Received a VIDI grant and multiple national/international grants. His lab leads the oLife Co-Fund consortium and participates in the MOSBRI research infrastructure. Grants & Leadership: Coordinates the oLife Fellowship Programme and chairs the Molecular Biophysics Lab. Active in steering committees for EU-funded initiatives. Labs/Teams: Heads the Molecular Biophysics Lab, focusing on viral dynamics and membrane systems. Collaborates globally on projects like ESCRT-III polymerization and antibiotic mechanisms.
Prof. Dr. Petra Schwille is a Director at the Max Planck Institute of Biochemistry and former C4 Professor of Biophysics at Dresden University of Technology . Her work spans molecular and cellular biophysics, synthetic biology, and single-molecule techniques. Academic disciplines: Natural sciences, biological sciences, physical sciences Key roles: Editorial Board member (Nature Methods, Biophysical Journal), Governing Council of Biophysical Society Research Focus includes membrane biophysics, protein interactions, and microfluidic systems. Her publications emphasize Fluorescence Correlation Spectroscopy (FCS) , receptor-ligand dynamics, and self-organization in bacterial cell division. Developed in vitro models for spatial regulation in cells Explored calmodulin availability and morphogen gradient formation Scientific Recognition includes prestigious awards like the Gottfried Wilhelm Leibniz Prize (2010) and the Biofuture grant (1998) . Max Planck Fellow (2005) Young Investigator Award (2003) Leadership & Service involves roles such as Dean of Studies for Nanobiophysics at TU Dresden and Vice Dean of the Dresden International Graduate School for Biomedicine and Bioengineering (DIGS-BB) . She also contributes to editorial and advisory boards in biophysics and science policy.
Quentin S. Fischer, Ph.D., is a Research Assistant Professor at the Fralin Biomedical Research Institute at Virginia Tech Carilion (VTC), where he conducts neuroscience research within the Friedlander Lab. His work focuses on synaptic plasticity mechanisms, particularly long-term potentiation (LTP) and depression (LTD), in the context of mild traumatic brain injury (mTBI) and neural rehabilitation through stimulation. Education: Ph.D. in Psychology (Neuroscience program), University of California, Riverside Master of Arts in Psychology (Neuroscience program), University of California, Riverside Bachelor of Arts in Psychology (Behavioral Neuroscience program), University of Colorado, Boulder Dr. Fischer's research explores how patterns of synaptic stimulation influence calcium signaling and plasticity in both normal and injured brains, aiming to optimize noninvasive neurostimulation therapies such as magnetic or optical stimulation. His prior work extensively examined visual cortex plasticity, ocular dominance, and molecular signaling pathways involving PKA and calcineurin. The publication trends reflect a deep engagement with synaptic and cortical plasticity, particularly in visual systems, spanning molecular, cellular, and systems-level neuroscience. His early work focused on developmental and experience-dependent plasticity in visual cortex, while recent research aims to translate these findings into therapeutic strategies for brain injury. Professional Experience: Instructor, Baylor College of Medicine (Neuroscience; Psychiatry & Behavioral Sciences) Postdoctoral Associate, Yale University Medical School, Dept. Ophthalmology & Visual Science Postdoctoral Research Associate, Ohio University, Neurobiology Program Graduate Student, University of California, Riverside Professional Research Associate II, University of Colorado Research Assistant, University of Colorado Dr. Fischer is actively involved in pre-clinical research and is part of the Friedlander Lab team, contributing to the development of evidence-based neural stimulation protocols for neurorehabilitation. No formal scientific awards or student mentorship details are listed in the provided text.
Miler T. Lee is an Associate Professor at the University of Pittsburgh , focusing on gene regulation during early embryonic development through high-throughput experimental and computational genomics. He earned his Ph.D. in Genomics and Computational Biology in 2009 from the University of Pennsylvania under Dr. Junhyong Kim, followed by postdoctoral work with Dr. Antonio Giraldez at Yale University. Joining the university in 2016, his research spans maternal-to-zygotic transition (MZT), RNA stability, pluripotency networks, and evolutionary developmental biology, utilizing model organisms like zebrafish, Xenopus, and Hydractinia symbiolongicarpus. Key Research Themes: Maternally inherited RNA dynamics during embryogenesis Mechanisms of RNA degradation and transcriptome remodeling Evolution of pluripotency networks in hybrid species Role of zinc signaling in fertilization barriers Computational tools for RNA regulation and sensing Scientific Awards: Pan-American Society for Evolutionary Developmental Biology Junior Faculty Award (2024) Outstanding New Investigator – International Xenopus Board (2023) Basil O'Connor Scholar – March of Dimes (2017-2019) Recent publications highlight his work on enhancer classification, RNA degradation mechanisms, and cross-species MZT comparisons. His lab develops innovative methods like RESA for regulatory sequence analysis and studies evolutionary divergence in RNA localization patterns. While the articles span computational and experimental approaches, they consistently address RNA's role in cellular identity, developmental timing, and evolutionary adaptation. Applications include understanding pluripotency, designing RNA biosensors, and elucidating fertilization barriers. Prospective Ph.D. students are encouraged to contact him for opportunities in gene regulation, development, evo-devo, and computational genomics.
Ario Sadafi is a researcher at the Technical University of Munich (TUM) , affiliated with the Chair of Computer Science Applications in Medicine under Prof. Nassir Navab. His work spans medical image analysis , machine learning , and computational pathology , with a strong focus on developing AI-driven solutions for microscopic imaging in hematology and oncology. Research Focus: Multiple Instance Learning for weakly supervised medical image classification. Explainable AI for biomedical single-cell imaging. Continual and cross-domain learning for robust diagnostic models. Microscopic image analysis for blood cell disorders and leukemia subtyping. Teaching Contributions: Sadafi has been actively involved in teaching courses such as Computer Aided Medical Procedures , Medical Augmented Reality , and Deep Learning for Medical Applications . He also supervises practical courses and seminars in 3D Computer Vision and Machine Learning in Medical Imaging . Labs & Collaborations: He works closely with the MEDIA (Medical Image Analysis) and NARVIS labs at TUM, contributing to projects in surgical data science , generative models , and robotics & ultrasound . Publications Impact: His research output (2018–2025) emphasizes AI-driven hematology , with applications in red/white blood cell classification, leukemia subtype diagnosis, and interpretable deep learning models for clinical use.
Kuo-Fen Lee, PhD is a Professor at the Salk Institute for Biological Studies, holding the prestigious Helen McLoraine Chair of Molecular Neurobiology. He leads the Clayton Foundation Laboratories for Peptide Biology, where his research focuses on nerve regeneration, spinal cord injury, and molecular mechanisms underlying neural development and neurodegenerative diseases. His work bridges basic neuroscience with potential therapeutic applications for conditions like ALS, paralysis, and Alzheimer's disease. Dr. Lee received his educational training from multiple prestigious institutions: a degree in Plant Pathology from National Taiwan University; an MS in Cancer Enzymology and Cell Differentiation from National Yang-Ming Medical College, Taiwan; a PhD in Endocrinology from Baylor College of Medicine, Houston; and completed his postdoctoral training at the Whitehead Institute for Biomedical Research. His primary research interests center on understanding why humans cannot regenerate damaged nerves while many other animals can. Dr. Lee has made significant discoveries regarding the p45 protein, which promotes nerve regrowth in mice but is absent in humans (who instead have p75, which inhibits nerve growth). His laboratory also studies neuregulin signaling, neuromuscular synapse formation, and the role of various proteins like nestin in neural development and maintenance. His work often employs mouse models to investigate spinal cord injury, pain pathways, and neurodegenerative conditions. Analysis of Dr. Lee's recent publications reveals a consistent focus on molecular neurobiology with particular emphasis on neural signaling pathways, synaptic maintenance, and nerve regeneration mechanisms. His research spans from basic molecular mechanisms to potential therapeutic applications, with increasing attention to pain pathways, Alzheimer's disease models, and the intersection of neuroscience with immunology and metabolism in recent years. As holder of the Helen McLoraine Chair of Molecular Neurobiology, Dr. Lee has received significant institutional recognition for his contributions to neuroscience. While specific awards aren't detailed in the provided text, his sustained funding and leadership position indicate substantial peer recognition in his field. Dr. Lee's research program involves extensive collaboration with other neuroscience laboratories, as evidenced by his numerous co-authored publications across various neuroscience subdisciplines. His work has been consistently funded, allowing for the maintenance of an active research laboratory focused on nerve regeneration and molecular neurobiology. The Clayton Foundation Laboratories for Peptide Biology serves as the primary research environment for Dr. Lee's team, where they investigate molecular mechanisms of nerve development, regeneration, and degeneration using advanced genetic, molecular, and cellular approaches. The laboratory maintains active research programs in multiple areas of neural signaling and development.
Professor Karl Peter Giese holds the position of Professor of Neurobiology of Mental Health and Co-Head of the Basic & Clinical Neuroscience Department at King's College London's Institute of Psychiatry, Psychology & Neuroscience (IoPPN). His research focuses on memory mechanisms in health and disease, particularly Alzheimer's pathology, synaptic dysfunction, and aging effects. He leads projects funded by Alzheimer's Research UK and other institutions, investigating molecular and cellular bases of memory storage. His work bridges experimental models (e.g., mice) with translational insights for clinical applications. He has over 140 publications, including high-impact studies on CYFIP proteins in dementia and CaMKII in synaptic plasticity. Collaborations include researchers at King's College London and international partners. His lab explores mechanisms linking amyloid-beta, tau, and synaptic proteins to cognitive decline, with recent work applying computational methods to model aging brains. Education: PhD from ETH Zurich (1992), MSc Chemistry from Ruhr-University Bochum (1989). Current grants include Alzheimer's Research UK Network Centres and studies on MNK inhibition for Alzheimer's therapies. Projects span protein synthesis dysregulation, thalamic amyloid pathology, and intellectual disability genetics. His research has been featured in Nature Neuroscience , Brain , and Neuron . He advises on translational neuroscience initiatives and mentors early-career researchers.
